SSUS State Opioid 2027 supports providers serving people who inject drugs, funding harm reduction, overdose prevention and response, and capital improvement planning to sustain those services in New Jersey.
SSUS HIV Services 2027 supports programs serving populations most affected by HIV, funding status-neutral testing, prevention, and care to engage people and link them to services designed around their needs.
SSUS Federal CDC Supplemental 2027 supports providers of HIV services with whole-person prevention, testing, PrEP initiation, and links to care to reduce new infections and improve health outcomes.
SSUS State STD Program 2027 supports New Jersey health agencies and service providers in funding STD investigations, safety-net testing, clinic expansion, and STD–HIV service integration.
Comprehensive Opioid, Stimulant, and Substance Use Program supports care for people with substance use disorder, funding diversion, harm reduction, and treatment to reduce arrest and incarceration.
Rapid Referral for Medications for Opioid Use Disorder: Telehealth 2027 supports a telehealth provider in urgently assessing patients and starting medication through telemedicine to improve access to care in New Jersey.